These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15046057)

  • 41. Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria.
    Ong PM; Lanyon WG; Hift RJ; Halkett J; Cramp CE; Moore MR; Connor JM
    Hum Hered; 1998; 48(1):24-9. PubMed ID: 9463797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of four mutations in six unrelated South African patients with acute intermittent porphyria.
    Ong PM; Lanyon WG; Hift RJ; Halkett J; Moore MR; Mgone CS; Connor JM
    Mol Cell Probes; 1996 Feb; 10(1):57-61. PubMed ID: 8684377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute intermittent porphyria: laboratory diagnosis by molecular methods.
    Schreiber WE
    Clin Lab Med; 1995 Dec; 15(4):943-56. PubMed ID: 8838232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of acute intermittent porphyria carriers by molecular biologic methods.
    Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
    Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nine mutations including three novel mutations among Russian patients with acute intermittent porphyria.
    Pischik E; Mehtälä S; Kauppinen R
    Hum Mutat; 2005 Nov; 26(5):496. PubMed ID: 16211556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase.
    Llewellyn DH; Whatley S; Elder GH
    Hum Mol Genet; 1993 Aug; 2(8):1315-6. PubMed ID: 8401516
    [No Abstract]   [Full Text] [Related]  

  • 47. Characterization of two missense variants in the hydroxymethylbilane synthase gene in the Israeli population, which differ in their associations with acute intermittent porphyria.
    Schneider-Yin X; Ulbrichova D; Mamet R; Martasek P; Marohnic CC; Goren A; Minder EI; Schoenfeld N
    Mol Genet Metab; 2008 Jul; 94(3):343-6. PubMed ID: 18406650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudoexon activation in the HMBS gene as a cause of the nonerythroid form of acute intermittent porphyria.
    Whatley SD; Mason NG; Rhodes JM; Stewart MF; Reed P; Crowley V; Darby CM; Badminton MN
    Clin Chem; 2013 Jul; 59(7):1123-5. PubMed ID: 23609978
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute intermittent porphyria: rapid molecular diagnosis.
    Puy H; Aquaron R; Lamoril J; Robréau AM; Nordmann Y; Deybach JC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):37-45. PubMed ID: 9074787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute intermittent porphyria presenting with a subarachnoid haemorrhage.
    van Heyningen C; Simms DM
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):610-1. PubMed ID: 18782811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of two novel mutations that produce acute intermittent porphyria: A 3-base deletion (841-843delGGA) and a missense mutation (T35M).
    De Siervi A; Weiss Cádiz DE; Parera VE; del C Batlle AM; Rossetti MV
    Hum Mutat; 2000 Oct; 16(4):373. PubMed ID: 11013452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of latent acute intermittent porphyria by genetic analysis.
    De Siervi A; Varela LS; Parera VE; Batlle AM; Rossetti MV
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):149-52. PubMed ID: 11269757
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria.
    Chen B; Solis-Villa C; Erwin AL; Balwani M; Nazarenko I; Phillips JD; Desnick RJ; Yasuda M
    J Inherit Metab Dis; 2019 Jan; 42(1):186-194. PubMed ID: 30740734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular basis of acute intermittent porphyria.
    Wood S; Lambert R; Jordan PM
    Mol Med Today; 1995 Aug; 1(5):232-9. PubMed ID: 17607885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-erythroid form of acute intermittent porphyria caused by promoter and frameshift mutations distant from the coding sequence of exon 1 of the HMBS gene.
    Whatley SD; Roberts AG; Llewellyn DH; Bennett CP; Garrett C; Elder GH
    Hum Genet; 2000 Sep; 107(3):243-8. PubMed ID: 11071386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute intermittent porphyria: vector optimization for gene therapy.
    Yasuda M; Domaradzki ME; Armentano D; Cheng SH; Bishop DF; Desnick RJ
    J Gene Med; 2007 Sep; 9(9):806-11. PubMed ID: 17654633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A large deletion on chromosome 11 in acute intermittent porphyria.
    Di Pierro E; Besana V; Moriondo V; Brancaleoni V; Tavazzi D; Casalgrandi G; Ventura P; Rocchi E; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):50-4. PubMed ID: 16828319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heteroduplex analysis detects frameshift and point mutations in patients with acute intermittent porphyria.
    Schreiber WE; Fong F; Nassar BA; Jamani A
    Hum Genet; 1995 Aug; 96(2):161-6. PubMed ID: 7635464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel mutation in a family with non-erythroid variant form of acute intermittent porphyria.
    Yu S; Poulos V; Stewart P
    J Hum Genet; 2000; 45(6):367-9. PubMed ID: 11185747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two Novel Hydroxymethylbilane Synthase Splicing Mutations Predispose to Acute Intermittent Porphyria.
    Zhang Y; Xiao H; Xiong Q; Wu C; Li P
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.